A new control switch could make RNA therapies easier to program

Using an RNA sensor, MIT engineers have designed a new way to trigger cells to turn on a synthetic gene. Their approach could make it possible to create targeted therapies for cancer and other diseases, by ensuring that synthetic ...

Biosensor could lead to new drugs, sensory organs on a chip

A synthetic biosensor that mimics properties found in cell membranes and provides an electronic readout of activity could lead to a better understanding of cell biology, development of new drugs, and the creation of sensory ...

Research into a means of in-body transport for cancer medicines

In a study, Bayreuth junior professor Dr. Meike Leiske has demonstrated which properties polymers should have in order to reach only certain cells. In the future, this should enable active substances to reach cancer cells ...

New 3D-printing ink could make cultured meat more cost-effective

Cultured meat (also known as cell-based or lab-grown meat) is a promising, more environmentally friendly alternative to meat produced from traditional livestock farming. However, production costs are still high and need to ...

Layered feedback mechanisms add control to engineered cells

Dr. Chelsea Hu, an assistant professor in the Artie McFerrin Department of Chemical Engineering at Texas A&M University and a member of the Accountability, Climate, Equity, and Scholarship (ACES) Faculty Fellows Program, ...

AI tailors artificial DNA for future drug development

With the help of an AI, researchers at Chalmers University of Technology, Sweden, have succeeded in designing synthetic DNA that controls the cells' protein production. The technology can contribute to the development and ...

page 2 from 22